Cardinal Capital Management, Inc. Amgen Inc Transaction History

Cardinal Capital Management, Inc.

$2.18 Billion
Q3 2024

A detailed history of Cardinal Capital Management, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Cardinal Capital Management, Inc. holds 850 shares of AMGN stock, worth $223,873. This represents 0.01% of its overall portfolio holdings.

Number of Shares

850

Previous 900 5.56%

Holding current value

$223,873

Previous $281,000 2.85%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$309.38 - $337.38 $15,469 - $16,869	-50 Reduced 5.56%	850 $273,000
Q2 2024 Jul 08, 2024	SELL	$262.75 - $319.31 $26,275 - $31,931	-100 Reduced 10.0%	900 $281,000
Q4 2023 Feb 23, 2024	SELL	$255.7 - $288.46 $364,372 - $411,055	-1,425 Reduced 58.76%	1,000 $288,000
Q3 2023 Oct 12, 2023	SELL	$218.65 - $271.46 $10,932 - $13,572	-50 Reduced 2.02%	2,425 $651,000
Q2 2023 Jul 10, 2023	SELL	$214.27 - $253.37 $26,783 - $31,671	-125 Reduced 4.81%	2,475 $549,000
Q1 2023 Apr 06, 2023	BUY	$225.79 - $275.2 $45,158 - $55,040	200 Added 8.33%	2,600 $628,000
Q2 2022 Jul 13, 2022	SELL	$230.71 - $256.74 $5,767 - $6,418	-25 Reduced 1.03%	2,400 $584,000
Q1 2022 Apr 12, 2022	SELL	$219.27 - $242.57 $16,445 - $18,192	-75 Reduced 3.0%	2,425 $586,000
Q3 2021 Oct 07, 2021	SELL	$212.27 - $248.7 $169,816 - $198,960	-800 Reduced 24.24%	2,500 $532,000
Q1 2021 Apr 14, 2021	SELL	$221.91 - $258.6 $66,573 - $77,580	-300 Reduced 8.33%	3,300 $821,000
Q4 2020 Jan 15, 2021	SELL	$216.38 - $257.67 $7,573 - $9,018	-35 Reduced 0.96%	3,600 $828,000
Q3 2020 Oct 13, 2020	SELL	$234.65 - $260.95 $18.7 Million - $20.8 Million	-79,871 Reduced 95.65%	3,635 $924,000
Q2 2020 Jul 08, 2020	SELL	$197.81 - $242.74 $27,693 - $33,983	-140 Reduced 0.17%	83,506 $19.7 Million
Q1 2020 Apr 08, 2020	SELL	$182.24 - $241.7 $241,103 - $319,769	-1,323 Reduced 1.56%	83,646 $17 Million
Q4 2019 Jan 15, 2020	SELL	$189.21 - $243.2 $477,755 - $614,080	-2,525 Reduced 2.89%	84,969 $20.5 Million
Q3 2019 Oct 08, 2019	SELL	$174.11 - $208.62 $23,678 - $28,372	-136 Reduced 0.16%	87,494 $16.9 Million
Q2 2019 Jul 11, 2019	SELL	$166.7 - $195.41 $95,352 - $111,774	-572 Reduced 0.65%	87,630 $16.1 Million
Q1 2019 Apr 04, 2019	BUY	$180.87 - $203.88 $16 Million - $18 Million	88,202 New	88,202 $16.8 Million
Q4 2018 Jan 14, 2019	SELL	$178.4 - $208.25 $14.8 Million - $17.2 Million	-82,685 Closed	0 $0
Q3 2018 Oct 05, 2018	SELL	$185.29 - $208.89 $39,837 - $44,911	-215 Reduced 0.26%	82,685 $17.1 Million
Q2 2018 Jul 05, 2018	BUY	$166.05 - $186.51 $2.5 Million - $2.8 Million	15,035 Added 22.15%	82,900 $15.3 Million
Q1 2018 Apr 06, 2018	BUY	$169.43 - $198.0 $1.24 Million - $1.45 Million	7,325 Added 12.1%	67,865 $11.6 Million
Q4 2017 Jan 18, 2018	BUY	$168.79 - $188.59 $9.53 Million - $10.7 Million	56,490 Added 1394.81%	60,540 $10.5 Million
Q3 2017 Oct 06, 2017	BUY	$167.29 - $191.0 $677,524 - $773,550	4,050	4,050 $755,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cardinal Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cardinal Capital Management, Inc. with notifications on news.

Account

Cardinal Capital Management, Inc. Amgen Inc Transaction History